Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adrenocortical Carcinoma × Sorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 42 Liver Neoplasms 7 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Pancreatic Neoplasms 3 Melanoma 3 Carcinoma, Renal Cell 3 Sarcoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Breast Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Relapsed Pediatric Solid Tumor 1 Portal Vein Tumor Thrombus 1 Neoplasms, Glandular and Epithelial 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Hemangiosarcoma 1 HCC 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Digestive System Neoplasms 1

Interventions

cabazitaxel 1 Sorafenib 1 Ritonavir 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Mitotane 1 Lymph Node Excision 1 Indinavir 1 IPI-549 1 Blood Specimen Collection 1 Adrenalectomy 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00786110 2009-02-24

PAXO

University of Turin, Italy

Phase 2 Unknown

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡